Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:53 PM
Ignite Modification Date: 2025-12-25 @ 12:17 PM
NCT ID: NCT02365961
Description: Both treatment are standard of care.
Frequency Threshold: 0
Time Frame: Patients were assessed throughout their study participation, from surgery through the 3 month follow up.
Study: NCT02365961
Study Brief: Hip Scope Fascia-iliaca (FI) Block Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
FI Block Fascia iliaca block consisting of up to 60 mL of 0.35% ropivicaine at a dose of 3 mg/kg (with adjuvants of 100 mcg clonidine \[per 60 mL\] and epinephrine 1:400,000) ropivicaine clonidine Epinephrine 0 None 0 41 1 41 View
Local Injection Local anesthetic in the hip joint consisting of 30cc of 0.5% Noropin Noropin 0 None 0 43 1 43 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hospital readmission SYSTEMATIC_ASSESSMENT General disorders None View